Literature DB >> 15798216

p75-Ras-GRF1 is a c-Jun/AP-1 target protein: its up regulation results in increased Ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells.

Virna D Leaner1, Howard Donninger, Chad A Ellis, Geoffrey J Clark, Michael J Birrer.   

Abstract

The c-Jun/AP-1 transcription complex is associated with diverse cellular processes such as differentiation, proliferation, transformation, and apoptosis. These different biological endpoints are likely achieved by the regulation of specific target gene expression. We describe the identification of Ras guanine nucleotide exchange factor 1, Ras-GRF1, by microarray analysis as a c-Jun/AP-1 regulated gene essential for anchorage-independent growth of immortalized rat fibroblasts. Increased Ras-GRF1 expression, in response to inducible c-Jun expression in Rat1a fibroblasts, was confirmed by both real-time PCR and Northern blot analysis. We show that c-Jun/AP-1 can bind and activate the Ras-GRF1 promoter in vivo. A 75-kDa c-Jun/AP-1-inducible protein, p75-Ras-GRF1, was detected, and the inhibition of its expression with antisense oligomers significantly blocked c-Jun-regulated anchorage-independent cell growth. p75-Ras-GRF1 expression occurred with a concomitant increase in activated Ras (GTP bound), and the activation of Ras was significantly inhibited by antisense Ras-GRF1 oligomers. Moreover, p75-Ras-GRF1 could be coprecipitated with a Ras dominant-negative glutathione S-transferase (GST) construct, GST-Ras15A, demonstrating an interaction between p75-Ras-GRF1 and Ras. A downstream target of Ras activation, Elk-1, had increased transcriptional activity in c-Jun-expressing cells, and this activation was inhibited by dominant-negative Ras. In addition, c-Jun overexpression resulted in an increase in phospho-AKT while phosphorylation of ERK1/2 remained largely unaffected. The inhibition of phosphatidylinositol 3-kinase (PI3K)-AKT signal transduction by Ly294002 and wortmannin significantly blocked c-Jun-regulated morphological transformation, while inhibition of basal MEK-ERK activity with PD98059 and U0126 had little effect. We conclude that c-Jun/AP-1 regulates endogenous p75-Ras-GRF1 expression and that c-Jun/AP-1-regulated anchorage-independent cell growth requires activation of Ras-PI3K-AKT signal transduction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798216      PMCID: PMC1069594          DOI: 10.1128/MCB.25.8.3324-3337.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions.

Authors:  T Kallunki; T Deng; M Hibi; M Karin
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

2.  Regulatory role of MEF2D in serum induction of the c-jun promoter.

Authors:  T H Han; R Prywes
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

3.  Regulated and constitutive activity by CDC25Mm (GRF), a Ras-specific exchange factor.

Authors:  H Cen; A G Papageorge; W C Vass; K E Zhang; D R Lowy
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

Review 4.  Proteins regulating Ras and its relatives.

Authors:  M S Boguski; F McCormick
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

5.  Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity.

Authors:  M C Gruda; K Kovary; R Metz; R Bravo
Journal:  Oncogene       Date:  1994-09       Impact factor: 9.867

6.  Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.

Authors:  U R Rapp; J Troppmair; T Beck; M J Birrer
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

7.  Expression of alternative forms of Ras exchange factors GRF and SOS1 in different human tissues and cell lines.

Authors:  C Guerrero; J M Rojas; M Chedid; L M Esteban; D B Zimonjic; N C Popescu; J Font de Mora; E Santos
Journal:  Oncogene       Date:  1996-03-07       Impact factor: 9.867

8.  Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor.

Authors:  S Y Chen; S Y Huff; C C Lai; C J Der; S Powers
Journal:  Oncogene       Date:  1994-09       Impact factor: 9.867

9.  Cloning and analysis of human cDNAs encoding a 140-kDa brain guanine nucleotide-exchange factor, Cdc25GEF, which regulates the function of Ras.

Authors:  W Wei; B Das; W Park; D Broek
Journal:  Gene       Date:  1994-12-30       Impact factor: 3.688

10.  Serum-regulated transcription by serum response factor (SRF): a novel role for the DNA binding domain.

Authors:  C S Hill; J Wynne; R Treisman
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more
  10 in total

1.  p27 suppresses arsenite-induced Hsp27/Hsp70 expression through inhibiting JNK2/c-Jun- and HSF-1-dependent pathways.

Authors:  Jinyi Liu; Dongyun Zhang; Xiaoyi Mi; Qing Xia; Yonghui Yu; Zhenghong Zuo; Wei Guo; Xuewei Zhao; Jia Cao; Qing Yang; Angela Zhu; Wancai Yang; Xianglin Shi; Jingxia Li; Chuanshu Huang
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

2.  Microarray analysis of Shigella flexneri-infected epithelial cells identifies host factors important for apoptosis inhibition.

Authors:  Christina S Faherty; D Scott Merrell; Cristina Semino-Mora; Andre Dubois; Aishwarya V Ramaswamy; Anthony T Maurelli
Journal:  BMC Genomics       Date:  2010-04-29       Impact factor: 3.969

3.  Transcriptomic and proteomic analyses of mouse cerebellum reveals alterations in RasGRF1 expression following in vivo chronic treatment with delta 9-tetrahydrocannabinol.

Authors:  Graziano Colombo; Francesco Rusconi; Tiziana Rubino; Angela Cattaneo; Enzo Martegani; Daniela Parolaro; Angela Bachi; Renata Zippel
Journal:  J Mol Neurosci       Date:  2008-06-27       Impact factor: 3.444

4.  Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism.

Authors:  Sonyo Shin; Takayuki Asano; Yixin Yao; Ronghua Zhang; Francois-Xavier Claret; Murray Korc; Kanaga Sabapathy; David G Menter; James L Abbruzzese; Shrikanth A G Reddy
Journal:  Mol Cancer Res       Date:  2009-05-12       Impact factor: 5.852

5.  RasGRF1 regulates proliferation and metastatic behavior of human alveolar rhabdomyosarcomas.

Authors:  Maciej Tarnowski; Gabriela Schneider; Gabriele Amann; Geoffrey Clark; Peter Houghton; Frederic G Barr; Lukas Kenner; Mariusz Z Ratajczak; Magda Kucia
Journal:  Int J Oncol       Date:  2012-06-28       Impact factor: 5.650

6.  Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.

Authors:  J Kikuchi; I Kinoshita; Y Shimizu; S Oizumi; M Nishimura; M J Birrer; H Dosaka-Akita
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

7.  Differences in flexibility underlie functional differences in the Ras activators son of sevenless and Ras guanine nucleotide releasing factor 1.

Authors:  Tanya S Freedman; Holger Sondermann; Olga Kuchment; Gregory D Friedland; Tanja Kortemme; John Kuriyan
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

8.  Oncogenic but non-essential role of N-myc downstream regulated gene 1 in the progression of esophageal squamous cell carcinoma.

Authors:  Wei Wei; Jacqueline C Bracher-Manecke; Xiaohang Zhao; Neil H Davies; Lanping Zhou; Runna Ai; Lisa Oliver; Francois Vallette; Denver T Hendricks
Journal:  Cancer Biol Ther       Date:  2012-11-28       Impact factor: 4.742

9.  Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant.

Authors:  Y Shimizu; I Kinoshita; J Kikuchi; K Yamazaki; M Nishimura; M J Birrer; H Dosaka-Akita
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

10.  A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression.

Authors:  Rui Sun; Zhong Zheng; Li Wang; Shu Cheng; Qing Shi; Bin Qu; Di Fu; Christophe Leboeuf; Yan Zhao; Jing Ye; Anne Janin; Wei-Li Zhao
Journal:  Mol Oncol       Date:  2020-11-09       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.